Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -2024202320222021202020192018201720162015 5 November 2019 Five Idylla™ Studies to be Published at ‘Association for Molecular Pathology’ Annual Meeting (US) Non-regulated information 25 October 2019 Biocartis Launches Liquid Biopsy Idylla™ ctEGFR Mutation Assay Non-regulated information 23 September 2019 Five Idylla™ Performance Studies to be Presented at ‘European Society for Medical Oncology’ congress Non-regulated information 5 August 2019 Study on Performance Data of Idylla™ NRAS-BRAF Mutation Assay at 71st AACC Annual Scientific Meeting in Anaheim, CA (US) Non-regulated information 1 June 2019 Biocartis and Kite Sign Agreement for Development of Assays supporting Kite’s Therapies Non-regulated information 16 May 2019 Idylla™ MSI Performance Study Selected for Publication at ASCO Conference Non-regulated information 23 April 2019 Biocartis Announces Global Collaboration with Covance Non-regulated information 12 March 2019 Biocartis and Bristol Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies Non-regulated information 28 February 2019 Biocartis announces CE-IVD marking of its Idylla™ MSI Test Non-regulated information 26 February 2019 Biocartis Places Its 1,000th Idylla™ Instrument with Geisinger in US Non-regulated information Pagination First page « First Previous page ‹‹ … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page ›› Last page Last »